0001062993-23-011389.txt : 20230517 0001062993-23-011389.hdr.sgml : 20230517 20230517162637 ACCESSION NUMBER: 0001062993-23-011389 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230515 FILED AS OF DATE: 20230517 DATE AS OF CHANGE: 20230517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Murphy Polly A. CENTRAL INDEX KEY: 0001829248 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38207 FILM NUMBER: 23932111 MAIL ADDRESS: STREET 1: C/O ATEA PHARMACEUTICALS, INC. STREET 2: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celcuity Inc. CENTRAL INDEX KEY: 0001603454 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 16305 36TH AVENUE N STREET 2: SUITE 100 CITY: MINNEAPOLIS STATE: MN ZIP: 55446 BUSINESS PHONE: 763-392-0767 MAIL ADDRESS: STREET 1: 16305 36TH AVENUE N STREET 2: SUITE 100 CITY: MINNEAPOLIS STATE: MN ZIP: 55446 FORMER COMPANY: FORMER CONFORMED NAME: Celcuity LLC DATE OF NAME CHANGE: 20140324 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0407 4 2023-05-15 0001603454 Celcuity Inc. CELC 0001829248 Murphy Polly A. 16305 36TH AVENUE N. SUITE 100 MINNEAPOLIS MN 55446 1 0 0 0 0 Common Stock 5000 D Stock Option (right to buy) 8.31 2032-09-12 Common Stock 10000 10000 D Stock Option (right to buy) 8.31 2032-09-12 Common Stock 16300 16300 D Stock Option (right to buy) 9.58 2023-05-15 4 A 0 11645 0 A 2033-05-15 Common Stock 11645 11645 D 2,500 shares vest on each of 9/12/23, 9/12/24, 9/12/25 and 9/12/26. Fully vested. This Option will vest and become exercisable on April 30, 2024, or if earlier, the date of the Company's 2024 Annual Meeting of Stockholders. /s/ Eric O. Madson as Attorney-in-Fact for Polly A. Murphy pursuant to Power of Attorney previously filed. 2023-05-17